Maternal Substance Use and Early-Life Adversity: Inducing Drug Dependence in Offspring, Interactions, Mechanisms, and Treatments.  Fadaei-Kenarsary M, Esmaeilpour K, Shabani M, Sheibani V.  Addict Health. 2024 Feb;16(1):51-66. doi: 10.34…

Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes.  Kanervo M, Tupola S, Nikkola E, Rantakari K, Kahila H.  Eur J Obstet Gynecol Reprod Biol. 2024 Apr 7;297:106-110…

Weaning buprenorphine in pregnant patients.  Patel N, O'Brien J, Cockerham C, Hawk G, Parilla B.  J Matern Fetal Neonatal Med. 2024 Dec;37(1):2337711. doi: 10.1080/14767058.2024.2337711. Epub 2024 Apr 14. PMID: 38616176. https://www.tan…

Evaluating the Effect of Maternal Opioid Maintenance Dose on the NOWS-COS Outcome Criteria: A Pilot Study.  Smith D, Sullivan R, Allen EC, Pradhan S, Zhu J, Oji-Mmuo CN.  Clin Pediatr (Phila). 2024 Apr 17:99228241246647. doi: 10.1177/000…

The maternal factors associated with infant low birth weight: an umbrella review.  Arabzadeh H, Doosti-Irani A, Kamkari S, Farhadian M, Elyasi E, Mohammadi Y.  BMC Pregnancy Childbirth. 2024 Apr 25;24(1):316. doi: 10.1186/s12884-024-0648…

Perception of pregnant individuals, health providers and decision makers on interventions to cease substance consumption during pregnancy: a qualitative study Vila-Farinas A, Pérez-Ríos M, Montes-Martínez A, Ahluwalia JS, Mourino N, Rey-Brandariz J…